$MRNY
1 analysts · 0 active debates

YieldMax MRNA Option Income Strategy ETF MRNY

Currently 0 bullish, 1 bearish — stable.

Analysts are holding steady at 0 bullish to 1 bearish.

1 YouTube analyst covers YieldMax MRNA Option Income Strategy ETF (MRNY).

1 analyst has covered MRNY so far…

Analyst opinions

Analyst opinions

drawdown risk outweighs YTD return

MRNY has produced a strong YTD total return (59.17%) this year but remains nearly 90% below its launch share price, so I would avoid allocating a large portion of an income portfolio to this single-stock covered-call ETF due to concentration risk.

Despite a 59% YTD total return, MRNY trades nearly 90% below its launch price, exposing income-portfolio investors to severe capital erosion. Concentration in a single-stock covered-call ETF magnifies downside risk that the elevated income yield does not adequately offset.

"These Are The Best High Yield Covered Call ETFs of 2026"

No official filings surfaced for MRNY yet.